# Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) Participants

> **NCT04657211** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1212 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **OTHER:** Prospective observational cohort study

## Key facts

- **NCT ID:** NCT04657211
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-14
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 1212 (ACTUAL)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04657211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04657211, "Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04657211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*